TR201906461T4 - Pirazol bileşiği ve bunun farmasötik kullanımı. - Google Patents
Pirazol bileşiği ve bunun farmasötik kullanımı. Download PDFInfo
- Publication number
- TR201906461T4 TR201906461T4 TR2019/06461T TR201906461T TR201906461T4 TR 201906461 T4 TR201906461 T4 TR 201906461T4 TR 2019/06461 T TR2019/06461 T TR 2019/06461T TR 201906461 T TR201906461 T TR 201906461T TR 201906461 T4 TR201906461 T4 TR 201906461T4
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical use
- pyrazole compound
- compound
- symbol
- pyrazole
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Aşağıdaki genel formül [Ib]'ye ait bir bileşik: , ki burada her sembol, tarifnamede tanımlananla aynıdır; veya bunun farmasötik açıdan edilebilir bir tuzu.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011188121 | 2011-08-31 | ||
| US201161573433P | 2011-09-06 | 2011-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201906461T4 true TR201906461T4 (tr) | 2019-05-21 |
Family
ID=66948704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/06461T TR201906461T4 (tr) | 2011-08-31 | 2012-08-30 | Pirazol bileşiği ve bunun farmasötik kullanımı. |
Country Status (7)
| Country | Link |
|---|---|
| ES (1) | ES2720366T3 (tr) |
| HR (1) | HRP20190730T1 (tr) |
| HU (1) | HUE043268T2 (tr) |
| LT (1) | LT3199533T (tr) |
| ME (1) | ME03416B (tr) |
| PT (1) | PT3199533T (tr) |
| TR (1) | TR201906461T4 (tr) |
-
2012
- 2012-08-30 ME MEP-2019-130A patent/ME03416B/me unknown
- 2012-08-30 HU HUE17157922A patent/HUE043268T2/hu unknown
- 2012-08-30 LT LTEP17157922.0T patent/LT3199533T/lt unknown
- 2012-08-30 ES ES17157922T patent/ES2720366T3/es active Active
- 2012-08-30 TR TR2019/06461T patent/TR201906461T4/tr unknown
- 2012-08-30 PT PT17157922T patent/PT3199533T/pt unknown
-
2019
- 2019-04-16 HR HRP20190730TT patent/HRP20190730T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ME03416B (me) | 2020-01-20 |
| HUE043268T2 (hu) | 2019-08-28 |
| ES2720366T3 (es) | 2019-07-19 |
| LT3199533T (lt) | 2019-06-25 |
| HRP20190730T1 (hr) | 2019-07-12 |
| PT3199533T (pt) | 2019-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4656638A3 (en) | Pyrazole compound and pharmaceutical use thereof | |
| PH12013502112A1 (en) | Amide compound and pharmaceutical application therefor | |
| AU2012328561A8 (en) | Benzoxazolinone compounds with selective activity in voltage-gated sodium channels | |
| EA201300200A1 (ru) | N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме | |
| MX2013002597A (es) | Arilpirrolidinas pesticidas. | |
| UA115320C2 (uk) | Інгібітори кінази | |
| PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| CO6741203A2 (es) | Derivados de biciclo[3,2,1]octilamida y sus usos | |
| IN2012DN01269A (tr) | ||
| MX361499B (es) | Baricitinib deuterado. | |
| MX2015001246A (es) | Ibrutinib deuterado. | |
| PH12013500942A1 (en) | Triazolopyridine compounds | |
| WO2013106761A3 (en) | Antimicrobial agents | |
| PH12015502178A1 (en) | Pyridinylpyrazoloquinoline compound | |
| MX346248B (es) | Derivados de [1,2,3]triazol[4,5-d]pirimidina como agonistas de los agonistas del receptor canabinoide 2. | |
| PH12014502743A1 (en) | Carbamate/urea derivatives | |
| WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
| MX342153B (es) | Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio. | |
| GB201305247D0 (en) | Amide Compounds | |
| MX2014015345A (es) | Inhibidores piranopiridona de tanquirasa. | |
| IN2014DN10669A (tr) | ||
| GB201020397D0 (en) | Compounds | |
| PH12013501487A1 (en) | 2-methoxy-pyridin-4-yl derivatives | |
| EA201301002A1 (ru) | Композиция | |
| PH12015500373A1 (en) | Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease |